IPF call options

How two under the radar IPF programs created $1.4 billion in market value

Surprise readouts from two programs in idiopathic pulmonary fibrosis have generated over $1.4 billion in market value, and there could still be plenty of upside ahead.

After market close on Aug. 7, FibroGen Inc. (NASDAQ:FGEN) reported that its

Read the full 375 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers